About Index Trending news
Analyze
Pricing
Exact Sciences

Exact Sciences

Exact Sciences

We manufacture Cologuard®, a noninvasive colon cancer screening test. Focused on the early detection and prevention of colorectal cancer.

Elsewhere

Alexa global traffic share

Twitter followers

Employees

Team size

500+
Locations
HQ
Xconomy

Exact Sciences Again Boosts Sales Projections for Flagship Product

Earnings Announcements
Xconomy

Exact Sciences To Sell 7 to 8 Million Shares in Stock Offering

Health
Xconomy

Shares in Exact Sciences Rise on UnitedHealthcare Coverage Decision

Health
Xconomy

Exact Sciences CEO Defends Company Against Short-Seller’s Criticism

Health
Xconomy

Exact Sciences Shares Rise After Company Beats Quarterly Forecasts

Earnings Health
Xconomy

Shares in Exact Sciences Rise on Better-Than-Expected P&L Results

Earnings Announcements
Xconomy

Exact Sciences, OnKöl, Fiserv, & More: This Week’s WI Watchlist

Xconomy

Exact Sciences Boosted By Investors, As Analysts Eye Profitability

Earnings Announcements
Xconomy

Exact Sciences, Fiserv, OneEvent, & More: This Week’s WI Watchlist

Health
Xconomy

Exact Sciences Shares Dip After Company Adjusts Revenue Forecast

Earnings Health
Xconomy

Kiio, HealthTech Capitol, & Exact Sciences: This Week’s WI Watchlist

Health
Xconomy

Exact Sciences, D2P, & Bon Ami: This Week’s Wisconsin Watchlist

Funding Health
The Motley Fool

Exact Sciences Shares Ignore the

Xconomy

Outlook Improves For Exact Sciences After Task Force Tweaks Ratings

Health People
The Motley Fool

Why Exact Sciences Stock Is Soaring 33% Today

The Motley Fool

Billionaire Battleground: Exact Sciences Inc.

The Motley Fool

Why Exact Sciences Stock Soared 10% Today

The Motley Fool

Bull Vs. Bear: Exact Sciences Corporation

The Motley Fool

Better Buy: Myriad Genetics, Inc. vs. Exact Sciences

The Motley Fool

Buy Exact Sciences Stock After a 72% Price Drop? 3 Things You Need to Know